SCHEMBL4435015

SCHEMBL4435015

O=C(NC1CCN(C(=O)O)CC1)c1ncc[nH]1

nearest known ligand 0.43

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ACKR3 P25106 1/20 0.41
SMYD3 Q9H7B4 1/20 0.41
EPHX1 P07099 1/20 0.38
HTR2B P41595 1/20 0.38
NPSR1 Q6W5P4 1/20 0.37
POLB P06746 1/20 0.37
JAK2 O60674 1/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
HTT P42858 1/20 0.36
CD38 P28907 1/20 0.36
EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2962867 0.85 SMYD3 (0.49) SMN1; SMN2L3MBTL1ACKR3SMYD3MEN1
SCHEMBL11878066 0.82 SMN1; SMN2 (0.58) SMN1; SMN2L3MBTL1ACKR3SMYD3MEN1
SCHEMBL27917306 0.82 OPRD1 (0.37) SMN1; SMN2ACKR3HTR2BHTT
SCHEMBL3682800 0.81 SMN1; SMN2 (0.56) SMN1; SMN2L3MBTL1ACKR3MEN1KMT2A
SCHEMBL27916927 0.81 HTR2B (0.37) SMN1; SMN2ACKR3HTR2BHTT
SCHEMBL27917391 0.80 OPRD1 (0.35) SMN1; SMN2L3MBTL1ACKR3SMYD3HTR2B
SCHEMBL27935665 0.80 BTK (0.42) SMN1; SMN2L3MBTL1ACKR3
SCHEMBL27935713 0.80 JAK3 (0.36) ACKR3HTR2B
SCHEMBL9651228 0.79 SIGMAR1 (0.61) L3MBTL1ACKR3POLBJAK2
SCHEMBL19710364 0.78 SMYD3 (0.61) SMN1; SMN2L3MBTL1SMYD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101959882-B Imidazole carbonyl compound DAIICHI SANKYO CO LTD 2013-09-11 CN disclosed
EP-2013211-A2 PURINE DERIVATIVES FOR USE AS ADENOSIN A2A RECEPTOR AGONISTS Novartis AG (CH) 2009-01-14 EP disclosed
WO-2007121920-A2 PURINE DERIVATIVES FOR USE AS ADENOSIN A2A RECEPTOR AGONISTS NOVARTIS AG (CH) 2007-11-01 WO disclosed